期刊文献+

白蛋白结合型紫杉醇对宫颈癌Caski细胞的抑制作用 被引量:3

Inhibitory effect of nanoparticle albumin- bound paclitaxel on cervical cancer Caski cells
原文传递
导出
摘要 目的:观察白蛋白结合型紫杉醇(nab-PC)对宫颈癌Caski细胞凋亡的影响并探讨其可能的机制。方法:将30只实验用615小鼠随机分为对照组和nab-PC组,于右腋窝下皮下接种0.1m L宫颈癌Caski细胞,连续15d。对照组右腋窝皮下注射0.9%氯化钠注射液0.2m L,nab-PC组右腋窝皮下注射nab-PC 0.2m L,均每周2次,治疗3周。采用免疫组化技术检测两组肿瘤组织中Bcl-2、Bax及Caspase-9的蛋白表达水平。结果:与对照组相比,nab-PC组Bcl-2蛋白表达水平明显降低,Bax、Caspase-9蛋白表达水平及Bax/Bcl-2比值明显升高,差异均有统计学意义(P<0.05)。结论:白蛋白结合型紫杉醇具有较强的促进宫颈癌Caski细胞凋亡的作用,其机制可能与增加Bax/Bcl-2比值和激活Caspase-9等有关。 Objective: To investigate the effect of nanoparticle albumin- bound paclitaxel( nab- PC) on the apoptosis of cervical cancer Caski cells and possible mechanism. Methods: A total of 30 experimental 615 mice were randomly divided into control group and nab- PC group,and subcutaneous inoculation of 0. 1 ml cervical cancer Caski cells in the right axilla were performed for 15 days continuously. The mice in the control group were given subcutaneous injection of 0. 9% sodium chloride 0. 2 ml in the right axilla,and those in the nab- PC group were given subcutaneous injection of nab- PC 0. 2 ml in the right axilla; the treatment was performed twice a week for 3 weeks in both groups. Immunohistochemistry was used to measure the protein expression of Bcl- 2,Bax,and caspase- 9 in tumor tissues in the two groups. Results: Compared with the control group,the nab- PC group showed a significant reduction in the protein expression of Bcl- 2 and significant increases in the protein expression of Bax and caspase- 9 and Bax /Bcl- 2 ratio( P〈0. 05). Conclusion: The nab- PC has a strong effect in promoting the apoptosis of cervical cancer Caski cells,and its mechanism of action may be related to an increased Bax / Bcl- 2 ratio and activation of caspase- 9.
作者 黄彤辉
出处 《湖南中医杂志》 2016年第5期184-185,共2页 Hunan Journal of Traditional Chinese Medicine
关键词 白蛋白结合型紫杉醇 宫颈癌CASKI细胞 小鼠 BCL-2 BAX CASPASE-9 实验研究 nanoparticle albumin-bound paclitaxel cervical cancer Caski cell mouse Bcl-2 Bax caspase-9 experimental study
  • 相关文献

参考文献6

  • 1Nyman DW,Campbell KJ,Hersh E,et al.Phase I and pharmacokinetics trial of ABI-007,a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies[J].J Clin Oncol,2005(23):7785-7793. 被引量:1
  • 2Sasaki Y,Nishina T,Yasui H,et al.Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer[J].Cancer Sci,2014(105):812-817. 被引量:1
  • 3W J Gradishar,D Krasnojon,S Cheporov,et al.Phase II trial of nab paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer:final analysis of overall survival[J].Clinical Breast Cancer,2012,12(5):313-321. 被引量:1
  • 4Yang SY,Zhang L,Miao KK,et al.Effects of selenium intervention on chronic fluorosis-induced renal cell apoptosis in rats[J].Biol Trace Elem Res,2011,144(13):1024-1031. 被引量:1
  • 5Richardson A,Kaye SB.Pharmacological inhibition of the bcl-2family of apoptosis regulators as cancer therapy[J].Curr Mol Pharmacol,2008(1):244-254. 被引量:1
  • 6Finnegan NM,Curtin JF,Prevost G,et al.In-duction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2interactions[J].Br JCancer,2001,85(1):115-121. 被引量:1

同被引文献30

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部